Skip to main content
All lobbying filings

BURRELL INTERNATIONAL GROUP LLC

Lobbying for CELLPHIRE, INC. · Biotechnology Company

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $40,000.00 income · posted Oct 18, 2025

Official filing document

 Lobbying activity 1
Health Issues

Pandemic and All Hazard Preparedness Act, FY26 LHHS and Defense Appropriations for next generation blood products; FY26 NDAA, FY26 LHHS and FY26 DoD Authorization and Appropriations for Freeze-dried platelet and next gen blood products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem